Elevation Oncology, Inc. (NASDAQ:ELEV) Sees Large Decline in Short Interest
Elevation Oncology, Inc. (NASDAQ:ELEV – Get Free Report) was the target of a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling 2,550,000 shares, a decrease of 42.4% from the May 15th total of 4,430,000 shares. Currently, 4.8% of the shares of the stock are […]
Elevation Oncology, Inc. (NASDAQ:ELEV – Get Free Report) was the target of a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling 2,550,000 shares, a decrease of 42.4% from the May 15th total of 4,430,000 shares. Currently, 4.8% of the shares of the stock are […]
